Diagnostic analysis of toxic damage due to a dose of zoledronic acid
Irina V. Gabbasova1, Valeria A. Sletova2, Alina D. Oksentyuk3, Irina L. Abisalova2, Kristina S. Gandylian1, Zhou Ling3, Roman R. Saltovets3, Zhanna I. Glushanyan2, Hasan A. Ordashev4, Arsen K. Shakhbanov4, Dmitry V. Mikhalchenko5, Said A. Shakhbanov4, Biyke R. Isaeva4, Asiyat A. Idrisova4, Oleg I. Admakin3, MarinaV. Loktionova3, Oksana V. Vorobyeva6, Tang Hui3, Aleksandr A. Sletov6
1Stavropol State Medical University, 310 Mira Str., Stavropol 355017 Russia
2Pyatigorsk Medical and Pharmaceutical Institute, 33 Kirov Ave., Pyatigorsk 357500 Russia
3Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8 Trubetskaya St. Bldg. 2., Moscow 119991 Russia
4Dagestan State Medical University, 1 Lenin Sq., Makhachkala 367000 Russia
5Volgograd State Medical University, 1 Pavshikh Bortsov Sq. Volgograd 400131 Russia
6Belgorod State National Research University (BelSU), 85 Pobedy St., Belgorod 308015 Russia
Corresponding author: Aleksandr A. Sletov (dr.sletov-aleksandr@yandex.ru)
Abstract
Introduction: Comprehensive analysis is necessary to analyze the widespread use of bisphosphonate drugs in the treatment and prevention of various diseases of connective tissue structures. The relevance of the study depends on the impact they have on the patient’s somatic condition, given the number of early and late complications diagnosed by domestic and foreign clinicians.
Materials and methods: The methodology used was developed on Stavropol Regional Clinical Hospital from 2010 to 2022. A randomized and observational study of the state of connective tissue structures was conducted in 186 patients who had a history of taking zoledronic acid and developed bisphosphonate osteonecrosis of the jawbone. At the diagnostic and treatment stages, patients were tested using laboratory methods to monitor amino acids in biological fluids (blood), as well as bone blocks extracted intraoperatively using highly effective gas-liquid chromatography on AAA 500.
Results and discussion: Aminograms obtained in the pre-operative period indicate toxic effects of zoledronic acid on neuro, endocrine, and other human systems. The initiation and progression of aseptic inflammatory processes in tissue structures is correlated with the deteriorating general ocular status of patients when amino acids, such as alanine, serine, taurine, phenylalanine, tyrosine, proline, histidine, glycine, and valine, against a background of 90.4±2.1 mmol/L ammonia are reduced critically.
Conclusion: Zoledronic acid initiates an aseptic chronic inflammatory process in the jaw bones, accompanied by toxic acidosis, which worsens osteoporotic symptoms.
Graphical abstract
Keywords: amino acids, highly effective gas-liquid chromatography, jawbone resection
Introduction
Bisphosphonate preparations have been widely used by various clinicists for more than 15 years, particularly aminobisphosphonates such as zoledronic acid (Rodionova et al. 2022). Most of the current safety studies for zoledronic acid use included patients with osteoporosis of various etiologies, in which osteonecrosis of jawbone was detected in only 4.5 percent of patients per 10,000 (Kim 2021; Everts-Graber et al. 2022). A small percentage of this complication of anti-sickness therapy, according to a number of studies, does not exclude caution in the use of zoledronic acid, especially in patients with malignant pathology requiring an aggressive, versatile approach, and polyprogrametic prescription of drugs.
The most commonly used drug is bisphosphonate that contains amines, and it has the highest affinity for hydroxylapatite and the most effective inhibition of farnesylpyrophosphatitase. Intravenously administered, the drug binds to bone tissue at a percentage of 55-61%. According to the instructions for the preparation, the half-life of T1/2 is 0.24 h and 1.87 h, without affecting the functioning of the enzymatic systems of the liver and having minimal nephrotoxic action when following the instructions for the application and control of creatine clearance, which shall not exceed 35 mL/mL (Dhillon 2016). It is known that the introduction of zoledronic acid in a number of patients is accompanied by side reactions, both early and late, the most common being influenza-like syndrome, which includes hyperthermia, weakness, nausea, and other symptoms. Mechanism is due to the inhibition of farnesylpyrophosphosphate synthase, which stimulates the production of monocytes of isopentenel pyrophosphate, resulting in the activation of gamma-delta CD14+ lymphocytes, which in the long term requires correction of treatment with bisphosphonic series drugs by the introduction of vitamin D3, to correct its insufficiency and drugs that eliminate hypocalcium, arising in the same conditions (Dhillon 2016; Rodionova et al. 2022).
Global analysis of initiator routes Bisphosphonate osteonecrosis is still in progress, the main etiologic factor of its pathogenesis is surgical aggression (tooth extraction, osteotomy of exostoses, etc.), whereas there is no initial pathophysiologic link. As the first link in every metabolic reaction in the human body, the authors of this study were prompted to analyze amino acid indices. In addition to lipids, carbohydrates, and nucleic acids, amino acids are involved in all of the cellular life processes of the body. In a dynamic balance to support life processes, amino acids are found in the body in both protein-bound and free states. Free amino acids perform a specific produces of degradation products that are responsible for maintaining optimal pH balance (Golovanova and Tomashevsky 2019). Highly efficient gas-liquid chromatography is the most informative and fastest method for the determination of amino acids in connective-tissue structures, which was the choice in its favor in the present study.
Materials and Methods
Group description
At the Department of Neurosurgery of Stavropol Regional Clinical Hospital from 2010 to 2022, 186 patients were subjected to examination and combined treatment. At the time of inclusion in the randomized, observational study, patients signed informed voluntary consents for participation in the study, photo-video recording of the clinical situation, use of specific laboratory methods of investigation, their interpretation and subsequent disclosure within the framework of scientific publishing activities, in particular the present article. Permission to conduct the present study No. 4 dated September 1, 2010, by the Ethical Committee оn Stavropol Regional Clinical Hospital. The age of the patients – 88 men and 98 women – included in the study ranged from 32 to 68 years. All patients were diagnosed with bisphosphonate osteonecrosis of jaw bones of different extent and localization. The criteria for inclusion in the study were the presence of a history of zoledronic acid intake in the absence of active infusion and/or oral intake at the time of the study (no therapeutic or maintenance load), informed voluntary consent to participate in the study. The exclusion criteria were: defined as: absence of bisphosphonate osteonecrosis of jaw bones, somatic diseases in the decompensation stage, their exacerbation, and lack of consent for inclusion in the study. acute vascular disorders, exacerbation of general vascular pathology and underlying pathology, taking zoledronic acid preparations.
Study design
For reliability, the analysis of indicators was performed at the inclusion stage, after the surgical stage (analysis of indicators in bone blocks). In addition to the patients’ aminograms, a standard list of clinical and laboratory tests, including for such parameters as glucose and ammonia, was also studied. The indices were analyzed by taking peripheral blood and morning urine.
Methods
The method of investigation was high-performance gas-liquid chromatography on an AAA 500 mass spectrometer (Ingos s.r.o., Czech Republic). Before entering the spectrometer, blood was centrifuged to isolate plasma to be analyzed. Plasma was then chemically deproteinized. Urine as well as blood was deproteinized. The amino acids studied are as follows: alanine, L-arginine, valine, glycine, histidine, lysine, proline, serine, taurine, phenylalanine, and tyrosine. The study of the mechanisms of initiation of metabolic acidosis determined the authors’ choice of amino acid spectrum. The presented clinical picture, as well as a number of standard diagnostic methods in connection with the knowledge obtained from domestic and foreign literature sources, allowed assuming a quantitative change and further laboratory confirmation of it.
Statistical analysis
The results were expressed as (M±m) and M(s). The percentage of the confidence interval was equal to 95%. The Student’s t-test was used for the comparison of the means between different groups, and within the same group in dynamics by using the ANOVA test of paired samples. Levels of significant (p<0.05) and reliable (p<0.001) differences in quantitative characteristics were assessed using non-parametric Mann-Whitney and Kraskell-Wallis criteria.
The level of statistical significance of the differences between the indicators was set at p<0.05.
Results and Discussion
At the time of preoperative examination, the biochemical analysis indices of interest to the authors such as markers of toxic analysis were as follows: glucose – 8.2±2.4 mmol/L and ammonia 90.4±6.2 mmol/L. Clinical evidence of 1 type diabetes prior to the use of zoledronic acid in patients had not been established by allied health professionals. The correlation of these indices associate with the severity of the general condition, with 30% characterized as moderate severity (56 patients) and 70% as severe severity (130 patients). The severity of the general condition was determined by general clinical and laboratory analysis and the quality of life criteria according to the MOS-36 questionnaire. Clinically, 65% of patients had functional fistulas (120 patients), and all the patients reported dysphagia, dysphonia, apathy, pain associated with limited mouth opening, and social discomfort. Critical reductions in the parameters of the amino acids of interest (Table 1) were detected by high-efficiency gas-liquid chromatography.
Table 1. |
Download as |
||
Quantitative amino acid profile of study patients in the preoperative period (mmol/L) |
Quantitative indicator, (mmol/L) |
Amino acid |
||||||||||
Reference values |
188.3-624.2 |
7.0-111.0 |
92.0-313.0 |
99.7-383.9 |
57.0-114.0 |
120.0-318.0 |
90.0-226.7 |
69.0-170.50 |
26.3-84.8 |
29.5-92.0 |
26.3-84.8 |
Pre-operative period |
3.95±0.42 |
2.1±0.05 |
4.1±0.1 |
1.61±0.04 |
1.45±0.04 |
3.26±0.05 |
2.92±0.2 |
1.63±0.05 |
1.61±0.05 |
0.87±0.02 |
1.26±0.1 |
ANOVA test, p<0.05 |
According to Loktionova et al. (2022), the alkalinization of blood plasma by the release of phosphate into the interstitial space provided a cascade chain of biochemical disorders leading to the depletion of cellular reserves, in particular for a number of amino acids; in addition, phosphate leaching from bone tissue increased the degree of osteomalacia and, as a consequence, could initiate bisphosphonate osteonecrosis. Alanine deficiency contributes to a decrease in other amino acids. It synthesizes leucine, isoleucine, valine, and serine. In the patients tested, alanine was reduced 49-fold to 3.95 mmol/L, which was probably the trigger for excessive protein catabolism, exacerbating plastic and regenerative processes. The identified L-arginine deficiency was the cause of atherosclerosis, hypertension and thrombus formation due to a gradual increase in vascular tone and impaired blood coagulation, which was clinically confirmed in the study. Such pathological processes led to the development of local ischemia in the maxillofacial region, which is one of the factors of bisphosphonate osteonecrosis. Also, impaired biosynthetic processes decreased the values of glycine from 194.2 to 1.61 mmol/L, which was found in significant amounts in collagen, has a function in the construction of proteins and participates in ammonia neutralization. The structure of the connective tissue has been negatively affected by the degenerative processes. Histidine deficiency had a negative effect on tissue regeneration, and also contributed to a decrease in the level of newly formed hemoglobin, which correlated with laboratory indicators -HbA1c (glycated Hb)- 4.9%. The determined serine deficiency (1.63 mmol/L) contributed to the loss of the neurotransmitter acetylcholine, which legitimately impaired the transmission of peripheral nerve impulses to the brain as well. The serine deficiency identified (1.63 mmol/L) contributed to the loss of the neurotransmitter acetylcholine, which, of course, also impaired the transmission of peripheral nerve impulses to the brain. Probably, the noted neuropathophysiologic processes contributed to a decrease in the secretory activity of salivary glands, which correlated with clinical data in 36% of patients. This factor also potentiated the development of a contractile dysfunction of the masticatory muscles, which occurred in 88% of the patients to a greater or lesser degree of severity. The development of secondary hypoparathyroidism was determined by a decrease in phenylalanine, a tyrosine precursor, and was clinically characterized by the development of hypercalcemia requiring drug correction. The mechanism of formation of pathological links of bisphosphonate osteonecrosis that led to disruption of the reparative cycle of bone is still not completely clear. The complex of conducted studies showed that plastic and regenerative processes in 82% of the examined patients were slow, and in 18% they were absent at all, against the background of limited or disturbed local metabolism in tissues, first of all, in periosteum, with the predominance of acidosis. In the area of ischemia, accumulation of lactic and pyruvic acids with predominance of glycosaminoglycan conversion of carbohydrates was detected, which was most likely the cause of osteogenesis inhibition.
Postoperatively, amino acid levels were evaluated in bone blocks taken during jaw resection (Table 2).
Table 2. |
Download as |
||
Quantitative composition of amino acids in bone blocks (%) |
Name of indicators |
Regulatory document on test methods |
Permitted levels |
Test results, % |
|
in absolute dry matter, % |
in the original substance, % |
|||
STATE STANDARD 32195 – 2013 (ISO 13903:2005) |
- |
2.58±0.05 |
1.60±0.5 |
|
- |
1.00±0.01 |
0.62±0.02 |
||
- |
1.30±0.02 |
0.80±0.05 |
||
- |
4.25±0.1 |
2.63±0.1 |
||
- |
3.30±0.4 |
2.04±0.1 |
||
- |
4.39±0.12 |
2.71±0.1 |
||
- |
3.18±0.05 |
1.96±0.1 |
||
- |
1.54±0.01 |
0.95±0.05 |
||
- |
0.43±0.01 |
0.27±0.01 |
||
- |
0.71±0.01 |
0.44±0.02 |
||
- |
1.92±0.05 |
1.19±0.1 |
||
- |
0.69±0.03 |
0.43±0.1 |
||
- |
1.16±0.05 |
0.72±0.05 |
||
- |
0.72±0.02 |
0.44±0.05 |
||
- |
1.94±0.04 |
1.20±0.04 |
||
- |
2.41±0.1 |
1.49±0.1 |
||
Amount of amino acids |
- |
31.54±0.2 |
19.49±0.1 |
|
Total humidity |
|
- |
- |
38.21±0.2 |
ANOVA test, p<0.05 |
The results indicated a deficiency of alanine. This resulted in an increased need for branched-chain amino acids (isoleucine, leucine, valine) in the body. These data are an indication that there was a slowdown in the development of regeneration processes and their incompleteness. Thin, nonhealing oral mucosa is more easily damaged by chewing (Ruggiero et al. 2022; Abisalova et al. 2023; Sletov et al. 2023). Such conditions facilitated microflora penetration and increased the likelihood of bisphosphonate osteonecrosis, which was clinically confirmed in the present study. The deficiency of isoleucine and leucine, in turn, was reflected in the loss of muscle mass, as it has been proved that it has an important role in obtaining energy from muscle glycogen, and its deficiency led to the manifestation of hypoglycemia (Anastasilakis et al. 2022; Gandylyan et al. 2023). The identified arginine deficiency contributed to endothelial dysfunction in vascular wall function (Shcheblykin et al. 2022). A number of morphological studies revealed significant lipid deposits in the arterial intima, which was clinically manifested by increased blood viscosity with signs of progressively developing atherosclerosis. As a result, reparative bone regeneration was impaired due to excessive accumulation of lactic and pyruvic acids, glycosaminoglycans, and deficient blood supply, leading to impaired periosteal metabolism, which, in turn, contributed to the inhibition of normal osteogenesis (Loktionova et al. 2022; Sogacheva et al. 2022; Martins et al. 2023).
A comparative aspect with the currently existing studies in the field of analysis of the content of amino acids could not be carried out due to their absence in the Russian and foreign literature sources (Polyakov et al. 2016; Amin et al. 2024; Fernandes et al. 2024). At the same time, the histologic characterization performed by numerous clinicians is consistent with the picture of bisphosphonate-induced osteonecrosis of the jaw with prevailing suppression of osteogenesis and increased cell-free mass in the resected block obtained by the Loktionova et al. (2022).
Conclusion
The toxic effect of zoledronic acid on the human body has been recorded by a number of researchers, while the mechanism of its initiation remains incompletely understood.
Influence on amino acid profile, actually one of the key links of practically any biochemical reaction, requires due attention and study, for the possibility of controlling early and late complications of therapy with the above-mentioned drug, which has positive dynamics of use in the treatment of the main pathology.
Conflict of interest
The authors have declared that no competing interests exist.
Funding
The authors have no funding to report. The authors have no support to report.
Data availability
All of the data that support the findings of this study are available in the main text or Supplementary information.
Reference
· Amin H, Andersen SWM, Jensen SS, Kofod T (2024) Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw located at tori: a retrospective study. Oral and Maxillofacial Surgery. https://doi.org/10.1007/s10006-024-01214-5. Epub ahead of print [PubMed]
· Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ (2022) Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: A critical review organized by the ECTS. The Journal of Clinical Endocrinology and Metabolism 107(5): 1441–1460. https://doi.org/10.1210/clinem/dgab888 [PubMed] [PMC]
· Dhillon S (2016) Zoledronic acid (Reclast®, Aclasta®): A review in osteoporosis. Drugs 76(17): 1683–1697. https://doi.org/10.1007/s40265-016-0662-4 [PubMed]
· Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, Häuselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T (2022) Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis. Journal of Bone and Mineral Research 37(2): 340–348. https://doi.org/10.1002/jbmr.4472 [PubMed]
· Fernandes TL, Viezzer Fernandes B, Franco GCN (2024) Treatment of medication-related osteonecrosis of the jaws without segmental resections: A case series. The American Journal of Case Reports 25: e942980. https://doi.org/10.12659/AJCR.942980 [PubMed] [PMC]
· Ferreira LH Jr, Mendonça KD Jr, Chaves de Souza J, Soares Dos Reis DC, do Carmo Faleiros Veloso Guedes C, de Souza Castro Filice L, Bruzadelli Macedo S, Soares Rocha F (2021) Bisphosphonate-associated osteonecrosis of the jaw. Minerva Dental and Oral Science 70(1): 49–57. https://doi.org/10.23736/S2724-6329.20.04306-X [PubMed]
· Gandylyan KS, Sletova VA, Gabbasova IV, Idrisova AM, Elsieva IS, Sletov AA (2023) Analysis of mineral elements in connective tissues in patients with bisphosphonate osteonecrosis. Russian Dental Journal [Rossiiskii Stomatologicheskii Zhurnal] 27(4): 311–321. https://doi.org/10.17816/dent472106 [in Russian]
· Golovanova IA,Tomashevsky OA(2019) Kinetics and thermodynamics of the formation of calcium ion compounds with amino acids, their structure and stability. Journal of Physical Chemistry [Zhurnal Fizicheskoi Khimii] 93(1): 11–22. https://doi.org/10.1134/S0044453719010084 [in Russian]
· Kim HY (2021) Review and update of the risk factors and prevention of antiresorptive-related osteonecrosis of the jaw. Endocrinology and Metabolosm 36(5): 917–927. https://doi.org/10.3803/EnM.2021.1170 [PubMed] [PMC]
· Loktionova MV, Gandylian KS. Kravan SN (2022) Monitoring of amino acid balance indicators in patients with bisphosphonate osteonecrosis of jawbone. New in the theory and practice of dentistry: Proceedings of the XXI Forum of Scientific and Practical Conference of Dentists of the South of Russia ”Actual Questions of Clinical Dentistry”, dedicated to the 75th anniversary of the birth of Professor V.I. Grechishnikov, Stavropol, April 21-22, pp. 159–161. [in Russian]
· Martins LHI, Ferreira DC, Silva MT, Motta RHL, Franquez RT, Bergamaschi CC (2023) Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review. Oral Diseases 29(1): 75–99. https://doi.org/10.1111/odi.14003 [PubMed]
· Polyakov KA, Medvedev YuA, Ivanyushko TP, Sedova MV (2016) Medicine-associated osteonecrosis of jaw: A comparative analysis of oral microflora in health, in case of osteomyelitis and osteonecrosis of jaws. Modern Science. 9: 83–87.
· Rodionova SS, Kolondaev AF, Torgashin AN, Solomyannik IA (2022) Zoledronic acid for osteoporosis and associated low energy fractures. Medical Council [Meditsinskii Sovet] 16(21): 163–173. https://doi.org/10.21518/2079-701X-2022-16-21-163-173 [in Russian]
· Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws-2022 update. Journal of Oral and Maxillofacial Surgery 80(5): 920–943. https://doi.org/10.1016/j.joms.2022.02.008 [PubMed]
· Shcheblykin DV, Bolgov AA, Pokrovskii MV, Stepenko JV, Tsuverkalova JM, Shcheblykina OV, Golubinskaya PA, Korokina LV (2022) Endothelial dysfunction: developmental mechanisms and therapeutic strategies. Research Results in Pharmacology 8(4): 115–139. https://doi.org/10.3897/rrpharmacology.8.80376
· Sogacheva VV, Syomkin VA (2022) Bisphosphonate-related osteonecrosis of the jaws. Dentistry [Stomatologiya] 101(6): 85–90. https://doi.org/10.17116/stomat202210106185[PubMed] [in Russian]
Author сontributions
Irina V. Gabbasova, maxillofacial surgeon, Stavropol State Medical University Clinic of Endoscopic and Minimally Invasive Surgery, Stavropol, Russia; e-mail: dr.gabbasova-i@yandex.ru; ORCID ID https://orcid.org/0000-0003-3850-4274. Definition of key aims and objectives; preparation of histological material (surgery); analysis and interpretation of the data obtained; drafting of the manuscript and its editorial revision.
Valeria A. Sletova, Lecturer, Department of Pathology, Pyatigorsk Medical and Pharmaceutical Institute, Pyatigorsk, Russia; e-mail: tazler@yandex.ru; ORCID ID https://orcid.org/0000-0002-7026-3506. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Alina D. Oksentyuk, Assistant Professor, Department of Pediatric, Preventive Dentistry and Orthodontics, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; e-mail: Oksentyuk_a_d@staff.sechenov.ru; ORCID ID https://orcid.org/0000-0001-5490-1128. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Irina L. Abisalova, Candidate of Medical Sciences (PhD), Head of the Department of Pathology, Pyatigorsk Medical and Pharmaceutical Institute, Pyatigorsk, Russia; e-mail: irabi@yandex.ru; ORCID ID https://orcid.org/0000-0002-3828-6759. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Kristina S. Gandylian, Candidate of Medical Sciences (PhD), Head of the Department of Surgical Dentistry and Maxillofacial Surgery, Stavropol State Medical University, Stavropol, Russia; e-mail: gandylian7@yandex.ru; ORCID ID https://orcid.org/0000-0003-3752-4752. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Zhou Ling, residency student, Department of Pediatric, Preventive Dentistry and Orthodontics, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; e-mail: ling19980528@gmail.com; ORCID ID https://orcid.org/0009-0009-1412-3689. Experimentation; analysis and interpretation of research results; and participation in scientific design.
Roman R. Saltovets, 3rd year student, Faculty of Medicine, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; e-mail: saltovetsr898@mail.ru; ORCID ID https://orcid.org/0000-0001-5737-8694. Development and design of methodology, definition of the key aims and objectives, critical revision of the manuscript and its analysis, and provision of valuable comments.
Zhanna I. Glushanyan, 2nd-year student, Faculty of Medicine, Pyatigorsk Medical and Pharmaceutical Institute, Pyatigorsk, Russia; e-mail: zhannochka07@yandex.ru; ORCID ID https://orcid.org/0009-0006-9402-0492. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Hasan A. Ordashev, Candidate of Medical Sciences (PhD), Head of the Department of Surgical Dentistry and Maxillofacial Surgery, Dagestan State Medical University, Makhachkala, Russia; e-mail: hasan005@mail.ru; ORCID ID https://orcid.org/0000-0002-4290-2665. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Arsen K. Shakhbanov, maxillofacial surgeon, Dagestan State Medical University, Makhachkala, Russia; e-mail: shahbanovars69@mail.ru; ORCID ID https://orcid.org/0009-0006-6637-3223. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Dmitry V. Mikhalchenko, Holder of Advanced Doctorate (D.Sc.), Head of the Department of Propedeutics of Dental Diseases, Volgograd State Medical University, Volgograd, Russia; e-mail: mdmitriystom@yandex.ru; ORCID ID https://orcid.org/0000-0002-0479-8588. Development and design of methodology, definition of the key aims and objectives, critical revision of the manuscript and its analysis, and provision of valuable comments.
Said A. Shakhbanov, maxillofacial surgeon, Dagestan State Medical University, Makhachkala, Russia; e-mail: saidars96@mail.ru; ORCID ID https://orcid.org/0009-0001-3313-3729. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Biyke R. Isaeva, Lecturer, Department of Surgical Dentistry and Maxillofacial Surgery, Dagestan State Medical University, Makhachkala, Russia; e-mail: isaevadrm@mail.ru; ORCID ID https://orcid.org/0009-0005-5449-4573. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Asiyat A. Idrisova, Lecturer, Department of Surgical Dentistry and Maxillofacial Surgery, Dagestan State Medical University, Makhachkala, Russia; e-mail: 005asal@mail.ru; ORCID ID https://orcid.org/0009-0007-2734-0725. Search for and analysis of information; animal keeping control, preparation and sampling of material for research; and participation in the analysis of the research results.
Oleg I. Admakin, Holder of Advanced Doctorate (D.Sc.), Professor, Department of Children and Preventive Dentistry, I.M. Sechenov First State Medical University, Moscow, Russia; e-mail: dr.admakinoi@yandex.ru; ORCID ID https://orcid.org/0000-0002-5626-2961. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comment.
Marina V. Loktionova, Holder of Advanced Doctorate (D.Sc.), Associate Professor, Department of Children and Preventive Dentistry, I.M. Sechenov First State Medical University, Moscow, Russia; e-mail: marina_staff-sehenov@yandex.ru; ORCID ID https://orcid.org/0000-0003-3555-2035. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Oksana V. Vorobyeva, Associate Professor of Biology, Belgorod State National Research University, Belgorod, Russia;e-mail: vorobyeva@bsu.edu.ru; ORCID ID https://orcid.org/0000-0003-0972-0074. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Tang Hui, residency student, Department of Orthodontics, Moscow State University of Medicine and Dentistry, Moscow, Russia; e-mail: orthodont.tanghui@yandex.ru, ORCID ID https://orcid.org/0009-0005-2092-8505. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Aleksandr A. Sletov, Holder of Advanced Doctorate (D.Sc.), Professor, Department of General Dentistry,Belgorod State National Research University, Belgorod, Russia; e-mail: dr.sletov-aleksandr@yandex.ru; ORCID ID https://orcid.org/0000-0001-5183-9330. Definition of the key aims and objectives; interpretation of the data obtained; critical revision of the manuscript, and provision of valuable comments.
Copyright (c) 2024 Irina V. Gabbasova, Valeria A. Sletova, Alina D. Oksentyuk, Irina L. Abisalova, Kristina S. Gandylian, Zhou Ling, Roman R. Saltovets, Zhanna I. Glushanyan, Hasan A. Ordashev, Arsen K. Shakhbanov, Dmitry V. Mikhalchenko, Said A. Shakhbanov, Biyke R. Isaeva, Asiyat A. Idrisova, Oleg I. Admakin, Marina V. Loktionova, Oksana V. Vorobyeva, Tang Hui, Aleksandr A. Sletov
This work is licensed under a Creative Commons Attribution 4.0 International License.